American Heart Journal
Volume 143, Issue 5 , Pages 768-776 , May 2002

Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival?

Received 2 May 2000 ,Accepted 11 December 2001.

References 

  1. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med. 1994;330:1724–1730
  2. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med. 1999;131:47–59
  3. Carnendran L, Abboud R, Sleeper LA, et al.  Trends in cardiogenic shock: report from the SHOCK study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. Eur Heart J. 2001;22:472–478
  4. Hochman JS, Boland J, Sleeper LA, et al.  Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation. 1995;91:873–881
  5. Eltchaninoff H, Simpfendorfer C, Franco I, et al.  Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment. Am Heart J. 1995;130:459–464
  6. Leor J, Goldbourt U, Reicher-Reiss H, et al.  Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. Am J Med. 1993;94:265–273
  7. Hands ME, Rutherford JD, Muller JE, et al.  The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. J Am Coll Cardiol. 1989;14:40–46
  8. Gheorghiade M, Anderson J, Rosman H, et al.  Risk identification at the time of admission to the coronary unit in patients with suspected myocardial infarction. Am Heart J. 1988;116:1212–1217
  9. Goldberg RJ, Samad NA, Yarzebski J, et al.  Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162–1168
  10. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico GISSI . Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397–402
  11. ISIS-2 Collaborative Group . Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349–360
  12. The GUSTO Investigators . An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–682
  13. Bengtson JR, Kaplan AJ, Pieper KS, et al.  Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992;20:1482–1489
  14. Berger PB, Holmes DR, Stebbins AL, et al.  Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial. Circulation. 1997;96:122–127
  15. Antoniucci D, Valenti R, Santoro GM, et al.  Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol. 1998;31:294–300
  16. Moosvi AR, Khaja F, Villanueva L, et al.  Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 1992;19:907–914
  17. Hibbard MD, Holmes DR, Bailey KR, et al.  Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol. 1992;19:639–646
  18. Gacioch GM, Ellis SG, Lee L, et al.  Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol. 1992;19:647–653
  19. Lee L, Erbel R, Brown TM, et al.  Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol. 1991;17:599–603
  20. Holmes DR, Bates ER, Kleiman NS, et al.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 trial experience. J Am Coll Cardiol. 1995;26:668–674
  21. Hochman JS, Sleeper LA, Webb JG, et al.  Early revascularization in myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–634
  22. Urban P, Stauffer J-C, Bleed D, et al.  A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. Eur Heart J. 1999;20:1030–1038
  23. Hochman J, Sleeper L, White H, et al.  Should we emergently revascularize occluded coronaries for cardiogenic shock: one-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190–192
  24. Krumholz HM, Chen J, Murillo JE, et al.  Admission to hospitals with on-site cardiac catheterization facilities. Circulation. 1998;98:2010–2016
  25. Every NR, Larson EB, Litwin PE, et al.  The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med. 1993;329:546–551
  26. Every NR, Parsons LS, Fihn SD, et al.  Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. Circulation. 1997;96:1770–1775
  27. Behar S, Hod H, Benari B, et al.  On-site catheterization laboratory and prognosis after acute myocardial infarction. Arch Intern Med. 1995;155:813–817
  28. Guadagnoli E, Hauptman P, Ayanian J, et al.  Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med. 1995;333:573–578
  29. Tu JV, Pashos CL, Naylor CD, et al.  Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med. 1997;336:1500–1505
  30. Rouleau JL, Moye LA, Pfeffer MA, et al.  A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med. 1993;328:779–784
  31. Selby JV, Fireman BH, Lundstrom RJ, et al.  Variation among hospitals in coronary angiography facilities and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med. 1996;335:1888–1896
  32. Barbash I, Behar S, Battler A, et al.  Management and outcome of cardiogenic shock complicating acute myocardial infarction in hospitals with and without on-site catheterisation facilities. Heart. 2001;86:145–149
  33. Vogel RA. HCFA's Cooperative Cardiovascular Project: a nationwide quality assessment of acute myocardial infarction. Clin Cardiol. 1994;17:354–356
  34. Jencks SF, Wilensky GR. The health care quality improvement initiative. JAMA. 1992;268:900–903
  35. Washington DC: Public Health Service, US Dept of Health and Human Services . International classification of diseases, ninth revision, clinical modification. 1988;
  36. Thiemann D, Coresh J, Oetgen W, et al.  The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med. 1999;340:1640–1648
  37. Marciniak TA, Ellerbeck EF, Radford MJ, et al.  Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351–1357
  38. Huff ED. Comprehensive reliability assessment and comparison of quality indicators and their components. J Clin Epidemiol. 1997;50:1395–1404
  39. Fleming C, Fisher ES, Chang CH, et al.  Study outcomes and hospital utilization in the elderly: the advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care. 1992;30:377–391
  40. Hosmer D, Lemeshow S. Applied logistic regression. New York: Wiley; 1989;
  41. Hanley J, McNeil BJ. The meaning and use of the area under the receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36
  42. Hochman JS, Sleeper LA, Godfrey E, et al.  Should we emergently revascularize occluded coronaries for cardiogenic shock: an international randomized trial of emergency PTCA/CABG-trial design. Am Heart J. 1999;137:313–321
  43. Webb JG, Carere RG, Hilton D, et al.  Usefulness of coronary stenting for cardiogenic shock. Am J Cardiol. 1997;79:81–84
  44. Weaver W, Simes R, Betriu A, et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093–2098
  45. Tiefenbrunn A, Chandra N, French W, et al.  Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the second national registry of myocardial infarction (NRMI-2). J Am Coll Cardiol. 1998;31:1240–1245

☆ The analyses upon which this publication is based were performed under Contract No. 500-96-P549, entitled “Utilization and quality control peer review organization for the state of Connecticut,” sponsored by the Health Care Financing Administration, Department of Health and Human Services. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. The author assumes full responsibility for the accuracy and completeness of the ideas presented. This article is a direct result of the Health Care Quality Improvement Program initiated by the Health Care Financing Administration, which has encouraged identification of quality improvement projects derived from analysis of patterns of care and therefore required no special funding on the part of this contractor. Ideas and contributions to the author concerning experience in engaging with issues presented are welcomed.

☆☆ Reprint requests: Harlan M. Krumholz, MD, Yale University School of Medicine, 333 Cedar St, PO Box 208025, New Haven, CT 06520-8025.

PII: S0002-8703(02)59714-3

doi: 10.1067/mhj.2002.122289

American Heart Journal
Volume 143, Issue 5 , Pages 768-776 , May 2002

Article Tools